Odisha News, Odisha Latest news, Odisha Daily - OrissaPOST
  • Home
  • Trending
  • State
  • Metro
  • National
  • International
  • Business
  • Feature
  • Entertainment
  • Sports
  • More..
    • Odisha Special
    • Editorial
    • Opinion
    • Careers
    • Sci-Tech
    • Timeout
    • Horoscope
    • Today’s Pic
  • Video
  • Epaper
  • News in Odia
  • Home
  • Trending
  • State
  • Metro
  • National
  • International
  • Business
  • Feature
  • Entertainment
  • Sports
  • More..
    • Odisha Special
    • Editorial
    • Opinion
    • Careers
    • Sci-Tech
    • Timeout
    • Horoscope
    • Today’s Pic
  • Video
  • Epaper
  • News in Odia
No Result
View All Result
OrissaPOST - Odisha Latest news, English Daily -
No Result
View All Result

Bharat Biotech to begin Phase-1 trials of its intranasal vaccine for COVID-19 in Feb-March

PTI
Updated: January 8th, 2021, 16:43 IST
in Coronavirus, Home News, National, Sci-Tech
0
Nasal Vaccine
Share on FacebookShare on TwitterShare on WhatsAppShare on Linkedin

Hyderabad: Bharat Biotech has already got emergency use authorisation of Covaxin from the Drug Controller General of India (DCGI). Now Bharat Biotech has said Phase-1 clinical trials of its new intranasal antidote for the killer virus will begin during February-March this year.

Besides Covaxin, the company has been actively working on developing another vaccine. It has tied up with Washington University School of Medicine in St Louis for the novel ‘chimp-adenovirus’ (Chimpanzee adenovirus), a single dose intranasal vaccine for COVID-19.

Also Read

Microsoft outage shows Big Tech isn’t too big to fail

2 hours ago
Pic - IANS

Delhi most polluted among 24 state and UT capitals

2 hours ago

“BBV154 (intranasal COVID-19 vaccine), preclinical testing has been completed for toxicology, immunogenicity and challenge studies. These studies have been conducted in the USA and India. Phase I human clinical trials will commence during Feb-March 2021,” an email reply from the city-based vaccine maker informed this agency. Phase I human clinical trials will be conducted in India, Bharat Biotech added.

The Phase-1 trials will be conducted in Saint Louis University’s Vaccine and Treatment Evaluation Unit, the company sources said. They added Bharat Biotech owns the rights to distribute the vaccine in all markets except USA, Japan and Europe.

Krishna Ella, chairman of Bharat Biotech had earlier said the company is focusing on the intranasal vaccine. This is because the existing vaccines require two dose intramuscular injections. A country like India needs 2.6 billion syringes and needles which may add up to pollution.

An intranasal vaccine will not only be simple to administer but reduce the use of medical consumables such as needles, syringes, etc. It will also significantly impact the overall cost of a vaccination drive.

“One drop of vaccine in each of the nostrils is sufficient,” Ella had said.

According to him, keeping several issues in mind Bharat Biotech tied up with Washington University School of Medicine. He had said Bharat Biotech envisions that it would scale this vaccine to one billion doses, translating into equal number of individuals being vaccinated receiving a single-dose regimen.

Bharat Biotech has successfully completed enrollment of 25,800 volunteers for the Phase-3 trials of its COVID-19 vaccine Covaxin.

 

Tags: Bharat BiotechCovaxinIntranasalMedicinevaccineWashington
ShareTweetSendShare
Suggest A Correction

Enter your email to get our daily news in your inbox.

 

OrissaPOST epaper Sunday POST OrissaPOST epaper

Click Here: Plastic Free Odisha

#MyPaperBagChallenge

Sisirkumar Maharana

December 12, 2019
#MyPaperBagChallenge

Ankita Balabantray

December 12, 2019
#MyPaperBagChallenge

Saishree Satyarupa

December 12, 2019
#MyPaperBagChallenge

Surya Sidhant Rath

December 12, 2019
#MyPaperBagChallenge

Sarfraz Ahmad

December 12, 2019
#MyPaperBagChallenge

Anshuman Sahoo

December 12, 2019
#MyPaperBagChallenge

Nishikant Rout

December 12, 2019
#MyPaperBagChallenge

Debasis Mohanty

December 12, 2019
#MyPaperBagChallenge

Subhajyoti Mohanty

December 12, 2019
#MyPaperBagChallenge

Sibarama Khotei

December 12, 2019
#MyPaperBagChallenge

D Rama Rao

December 12, 2019
#MyPaperBagChallenge

Shreyanshu Bal

December 12, 2019
#MyPaperBagChallenge

Amritansh Mishra

December 12, 2019
#MyPaperBagChallenge

Pratyasharani Ghibela

December 12, 2019
#MyPaperBagChallenge

Arya Ayushman

December 12, 2019
#MyPaperBagChallenge

Priyasha Pradhan

December 12, 2019
#MyPaperBagChallenge

Ipsita

December 12, 2019
#MyPaperBagChallenge

Bijswajit Pradhan

December 12, 2019
#MyPaperBagChallenge

Narendra Kumar

December 12, 2019
#MyPaperBagChallenge

Adweeti Bhattacharya

December 12, 2019
#MyPaperBagChallenge

Tapaswini Mallick

December 12, 2019
#MyPaperBagChallenge

Vandana Singh

December 12, 2019
#MyPaperBagChallenge

Rajashree Manasa Mohanty

December 12, 2019
#MyPaperBagChallenge

Aman Kumar Barisal

December 12, 2019
#MyPaperBagChallenge

Mandakini Dakua

December 12, 2019
#MyPaperBagChallenge

Jhili Jena

December 12, 2019
#MyPaperBagChallenge

Ramakanta Sahoo

December 12, 2019
#MyPaperBagChallenge

Akshaya Kumar Dash

December 12, 2019
#MyPaperBagChallenge

Manas Samanta

December 12, 2019
#MyPaperBagChallenge

Sarmistha Nayak

December 12, 2019

Archives

Editorial

Tough Times

Press
November 16, 2026

Press freedom has, for years, been under attack almost everywhere across the globe, but the situation has never been as...

Read moreDetails

Democracy Strikes Back

Rights & Restrictions: AAKAR PATEL
November 15, 2026

By Aakar Patel Democracies correct themselves through elections. The leadership of every nation is imperfect, and the problems become especially...

Read moreDetails

The Trade Tightrope

DILIP CHERIAN
November 14, 2026

By Dilip Cherian While there is a diplomatic thaw between India and Canada, turning it into a meaningful trade pact...

Read moreDetails

Owners Of The Earth

November 11, 2026

The infidelity of the Nvidia co-founder, Jensen Huang, the AI tech giant company’s CEO, who recently admitted he had been...

Read moreDetails
  • Home
  • State
  • Metro
  • National
  • International
  • Business
  • Editorial
  • Opinion
  • Sports
  • About Us
  • Advertise
  • Contact Us
  • Jobs
Developed By Ratna Technology

© 2025 All rights Reserved by OrissaPOST

  • News in Odia
  • Orissa POST Epaper
  • Video
  • Home
  • Trending
  • Metro
  • State
  • Odisha Special
  • National
  • International
  • Sports
  • Business
  • Editorial
  • Entertainment
  • Horoscope
  • Careers
  • Feature
  • Today’s Pic
  • Opinion
  • Sci-Tech
  • About Us
  • Contact Us
  • Jobs

© 2025 All rights Reserved by OrissaPOST

    • News in Odia
    • Orissa POST Epaper
    • Video
    • Home
    • Trending
    • Metro
    • State
    • Odisha Special
    • National
    • International
    • Sports
    • Business
    • Editorial
    • Entertainment
    • Horoscope
    • Careers
    • Feature
    • Today’s Pic
    • Opinion
    • Sci-Tech
    • About Us
    • Contact Us
    • Jobs

    © 2025 All rights Reserved by OrissaPOST